de Wit H

Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, Illinois, USA.

22 papers · 1 preprint · ORCID

ArticleMDMA

Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study.

Colcott J, Guerin AA, Carter O +10

Europe PMC2026
ArticleLSD

Reward-related neural activity after low doses of LSD in participants with depressed mood.

Glazer J, Molla H, Lee R +2

Europe PMC2026
ArticlePsilocybin

Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions, by Griffiths et al.

de Wit H

Europe PMC2025
ArticleLSD

m-DASC: Measuring Subjective Effects of Very Low Doses of Psychedelic Drugs.

Griffin-Stolbach J, Molla H, Hedeker D +1

Europe PMC2026
ArticleMDMA

The effect of methamphetamine and 3,4-methylenedioxymethamphetamine on peripheral endocannabinoid concentrations: a study in healthy adults.

Deutsch A, Haggarty CJ, Petrie GN +4

Europe PMC2026
ArticleMDMA

The empathogen 3,4-methylenedioxymethamphetamine, but not methamphetamine, increases feelings of global trust.

Martinez RL, Radošić N, Molla H +2

Europe PMC2026
ArticleMDMA

MDMA as well as amphetamine and alcohol increase feelings of social closeness in healthy adults.

de Wit H, Hahn E, Smadi S +2

Europe PMC2024
ArticleLSD

Low-Dose LSD Alters Early and Late Event-Related Potentials to Emotional Faces.

Haggarty C, Molla H, Glazer J +4

Europe PMC2024
ArticleMDMA

MDMA modulates human sensorimotor cortical pathways during gentle touch.

Molla H, Novembre G, Bershad A +4

Europe PMC2024
ArticleMDMA

The 3,4-methylenedioxymethamphetamine enhances early visual processing for salient socio-emotional stimuli.

Haggarty CJ, Bershad AK, Kumar MK +2

Europe PMC2024
ArticleLSD

Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine.

Murray CH, Frohlich J, Haggarty CJ +3

Europe PMC2024
ArticleLSD

Microdosing Psychedelics: Current Evidence From Controlled Studies.

Murphy RJ, Muthukumaraswamy S, de Wit H

Europe PMC2024
ArticleLSD

Greater subjective effects of a low dose of LSD in participants with depressed mood.

Molla H, Lee R, Tare I +1

Europe PMC2024
ArticleMDMA

Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia.

Bershad AK, de Wit H

Europe PMC2023
ArticlePsychedelics

Does acute stress play a role in the lasting therapeutic effects of psychedelic drugs?

de Wit H, Heilig M, Bershad AK

Europe PMC2023
ArticleMDMA

The acute effects of psychoactive drugs on emotional episodic memory encoding, consolidation, and retrieval: A comprehensive review.

Doss MK, de Wit H, Gallo DA

Europe PMC2023
ArticleLSD

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity.

Glazer J, Murray CH, Nusslock R +2

Europe PMC2023
PreprintPsilocybin

Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory

Doss MK, Samaha J, Barrett FS +4

Europe PMC2022
ArticleLSD

Repeated low doses of LSD in healthy adults: A placebo-controlled, dose-response study.

de Wit H, Molla HM, Bershad A +2

Europe PMC2022
ArticleLSD

Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.

Murray CH, Tare I, Perry CM +3

Europe PMC2022
ArticleMDMA

Effects of Acute Drug Administration on Emotion: A Review of Pharmacological MRI Studies.

Van Hedger K, Mayo LM, Bershad AK +2

Europe PMC2021
ArticleLSD

Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity.

Bershad AK, Preller KH, Lee R +4

Europe PMC2020
ArticleLSD

Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers.

Bershad AK, Schepers ST, Bremmer MP +2

Europe PMC2019